Lipitor and Breast neoplasm - a phase IV clinical study of FDA data

Summary:

Breast neoplasm is reported as a side effect among people who take Lipitor (atorvastatin calcium), especially for people who are 60+ old, have been taking the drug for 2 - 5 years also take Singulair, and have Arthritis.

The phase IV clinical study analyzes which people have Breast neoplasm when taking Lipitor. It is created by eHealthMe based on reports of 251,142 people who have side effects when taking Lipitor from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,050 Lipitor users. Check the latest studies of Lipitor.

What is Breast neoplasm?

Breast neoplasm (non cancerous tumour of breast) is found to be associated with 188 drugs and 202 conditions by eHealthMe. Check the latest studies of Breast neoplasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

251,142 people reported to have side effects when taking Lipitor.
Among them, 42 people (0.02%) have Breast neoplasm.

Among these 42 people:

How long have people been on Lipitor when they have Breast neoplasm? *

What is the age of people who have Breast neoplasm when taking Lipitor? *

What are other drugs people take besides Lipitor? *

What are other side effects people have besides Breast neoplasm? *

Asthma: 21 people, 50.00%
Pulmonary Mass: 21 people, 50.00%
Acute Respiratory Failure: 20 people, 47.62%
Rashes (redness): 20 people, 47.62%
Neurosensory Hypoacusis (a type of hearing loss in which the root cause lies in the vestibulocochlear nerve): 20 people, 47.62%
Breath Sounds Abnormal: 20 people, 47.62%
Oral Candidiasis (fungal infection of mouth): 20 people, 47.62%
Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration): 20 people, 47.62%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 20 people, 47.62%
Osteoporosis (bones weak and more likely to break): 20 people, 47.62%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 7.14%
Stress And Anxiety: 1 person, 2.38%
Ovarian Cancer (cancer of ovary): 1 person, 2.38%
Osteoporosis (bones weak and more likely to break): 1 person, 2.38%
Metastases To Bone (cancer spreads to bone): 1 person, 2.38%
Inflammatory Bowel Disease: 1 person, 2.38%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 2.38%
Heart Attack: 1 person, 2.38%
Breast Cancer: 1 person, 2.38%
Asthma: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and have Breast neoplasm?

- Check whether Breast neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lipitor:

Lipitor (259,050 reports)

Breast neoplasm treatments and more:

Breast neoplasm (3,090 reports)

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast neoplasm:

Breast neoplasm (188 drugs)

Browse all the conditions that are associated with Breast neoplasm:

Breast neoplasm (202 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Lipitor) and Lipitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.